Latest
Markets MAYBAKER

Closing prices from 19 Oct 2026

Last refreshed Oct 19, 2026 17:00 WAT

MA

May & Baker NigeriaMAYBAKER

HEALTHCARE NGX
₦39.75 ₦0.00 (0.00%)

closing price · trade date October 19, 2026

Ride this chart
Price
₦39.75
October 19, 2026
0.00%

Key Trading Data

Latest imported Nigerian Exchange session data.

Open
₦39.75
Previous close
₦39.75
High
Not reported
Low
Not reported
Volume
602,184
Value traded
₦23,015,249.10
Trades
240
Market
Main Board
Currency
NGN

About May & Baker Nigeria

May & Baker Nigeria Plc is a pioneering healthcare and pharmaceutical manufacturing company listed on the Nigerian Exchange, specializing in the production of high-quality medicines and consumer health products.

Established in 1944, May & Baker is one of Nigeria's oldest pharmaceutical companies. Over the decades, it has evolved from a sales and distribution outpost into a major player in the West African healthcare landscape, producing a wide array of therapeutic formulations and consumer health products.

The company's operations are supported by its manufacturing facility in Ota, Ogun State. This facility allows May & Baker to maintain high-quality production pipelines for essential medications, ensuring the local market has consistent access to critical pharmaceutical therapeutics.

Through strategic partnerships, including a joint venture with the Federal Government of Nigeria under Biovaccines Nigeria Limited, the company aims to support local vaccine production. This initiative is intended to support Nigeria's vaccine self-sufficiency and public-health preparedness, subject to execution and regulatory progress.

Sector
Healthcare
Industry
Pharmaceuticals
Year Founded
1944
Market Segment
Main Board

Fundamentals & Ratios

Company metrics where available.

Reporting Currency
Nigerian Naira (NGN)

Local Manufacturing Capacity

The company operates a pharmaceutical manufacturing facility in Ota, Ogun State, which the company has described as built to international/GMP standards. This facility supports domestic production of pharmaceutical and consumer health products, as well as the company's overall manufacturing and distribution operations.

Strategic Initiatives in Immunization

May & Baker has a joint-venture relationship with the Federal Government through Biovaccines Nigeria Limited aimed at local vaccine production. This initiative is intended to support Nigeria's vaccine self-sufficiency and public-health preparedness, subject to execution and regulatory progress.

More

We use essential cookies for sign-in, security, and saving your competition session. Read our Privacy Policy.